Clinical TrialsSearch results
Number of results: 371
Other
- Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
- Cholestatic Pruritus in Participants With Primary Biliary Cholangitis
- Okamasa Arisa
- 2021-07-30
Recruiting
- Examination of stabilization of sedation by Nasal High Flow in patients with endoscopic retrograde cholangiopancreatography during sedation using Dexmedetomidine
- Biliary disease
- Ayuse Takao
- 2021-07-28
Completed
- The additive effect of lip strip to oral appliance therapy for obstructive sleep apnea
- obstructive sleep apnea
- Ootsuru Mitsunobu
- 2021-07-27
Completed
- Caries suppression effect of Clearfil Megabond FA
- initial dental caries
- Nishimata Haruka
- 2021-07-26
Completed
- A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
- Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome
- Contact Local
- 2021-07-19
Completed
- Efficacy of corticosteroid irrigation of the major salivary glands for xerostomia following head and neck cancer radiotherapy
- xerostomia
- Takagi Yukinori
- 2021-04-30
Completed
- CAM (Clarithromycin) Effectivity for COVID-19 pneumonia which does not require oxygen administration; multicenter, randomized-controlled, open-label, 3-armed parallel group comparison, exploratory trial
- COVID-19 pneumonia which does not require oxygen administration
- Mukae Hiroshi
- 2021-04-13
Recruiting
- The additive effect of antimicrobial photodynamic therapy for peri-implant disease
- Peri-implantitis
- Odatsu Tetsurou
- 2021-03-31
Completed
- Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to conventional synthetic disease-modifying antirheumatic drugs: Comparative study with Filgotinib and interleukin 6 inhibitor examined by clinical index as well as musculoskeletal ultrasound assessment(TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial
- Rheumatoid arthritis
- Kawakami Atsushi
- 2021-03-03
Other
- A Phase 3, Double-Blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
- Anemia associated with myelofibrosis
- Jin Hayakawa
- 2021-01-15